Generic-Drug Cos. Get State AGs' Trial Order Flipped

By Matthew Perlman · December 19, 2024, 6:29 PM EST

A Connecticut federal court has sided with the generic-drug makers accused of price-fixing by state-level enforcers and will allow a narrower case involving 15 drugs to move ahead prior to a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Connecticut et al v. Aurobindo Pharma USA, Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

December 15, 2016

Case Title

Connecticut et al v. Teva Pharmaceuticals USA, Inc.

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

May 10, 2019

Case Title

Connecticut et al v. Sandoz, Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

June 10, 2020

Recent Articles By Matthew

March 07, 2025
Ohio, PBMs Say High Court Ruling Didn't End Pricing Appeal
March 06, 2025
FTC Challenges PE Firm's Medical Device Coatings Deal
March 05, 2025
DOJ Fights Bid To Pause Piece Of Amedisys Merger Case
March 04, 2025
PBMs Ask 8th Circ. To Pause FTC's Insulin Pricing Case
March 03, 2025
Credit Bureaus Look To Duck Renewed Medical Debt Claims
February 28, 2025
Robotic Surgery Co. Appealing Tossed Intuitive Antitrust Case
February 06, 2025
UnitedHealth Drops Bid To Toss Home Health Deal Challenge
January 28, 2025
4th Circ. Raises Questions Over Health Data Access Order
January 28, 2025
Minn. AG Settles Novo Nordisk Insulin Claims With Price Cap
January 17, 2025
MultiPlan Wants Antitrust Claims Over Pricing Tools Tossed